Nanomedicine News

RSS

Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Researchers at the Cedars-Sinai Heart Institute infused antibody-studded iron nanoparticles into the bloodstream to treat heart attack damage. The combined nanoparticle enabled precise localization of the body's own stem cells to the injured heart muscle.

11 Sep 2014

Senesco Technologies Changes Name to Sevion Therapeutics

Senesco Technologies, Inc., a clinical-stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today a corporate rebranding under which the Company will change its name to Sevion Therapeutics, Inc.

10 Sep 2014

NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reported further progress in its anti-Ebola drug development program. The Company has designed novel anti-Ebola broad-spectrum drug candidates that are expected to continue to work in spite of mutations, and has commenced synthesis of the same.

From NanoViricides, Inc 10 Sep 2014

Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Dr. Sangeeta Bhatia, biomedical engineer and professor at MIT, is the recipient of the 2014 $500,000 Lemelson-MIT Prize. Bhatia is recognized for designing and commercializing miniaturized technologies with applications to improve human health.

10 Sep 2014

Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced pre-clinical data presented on Sunday, September 7, 2014, at 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC.

From Novavax Inc. 9 Sep 2014

PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

PharmAthene, Inc. and Nanotherapeutics, Inc., a privately-held biopharmaceutical company, announced today that they have formed a Strategic Alliance to advance the development of certain medical countermeasures for the U.S. biodefense market.

9 Sep 2014

SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

The newly merged SUNY College of Nanoscale Science and Engineering (CNSE)/SUNY Institute of Technology (SUNYIT) institution today announced the National Institute of Environmental Health Sciences has awarded a $1.65 million grant to further research conducted by nanobioscience professor Dr. Thomas Begley that identifies signals which cancer cells use to respond to their environment.

9 Sep 2014

Diagnostic Tool for Therapeutic Plasma Medicine

The potential for deployment of cold plasma sources in medical and biological applications continues to increase in areas such as dentistry, surgery, wound sterilisation and general surface decontamination. Successful optimisation of these gas-phase cold plasmas requires detailed characterisation and quantification of the plasma beam to establish the actual abundances of the reactive species within the feed-gas and the variances with feed-gas composition.

From Hiden Analytical 8 Sep 2014

Novavax Presents Preclinical Data on RSV F-Protein Nanoparticle Vaccine Candidate at ICAAC 2014

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today presented preclinical data demonstrating that antibodies generated to its RSV F-protein nanoparticle vaccine candidate (RSV F vaccine) bind to the site II epitope of the RSV F-protein with a higher affinity than palivizumab (Syangis®) at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC.

8 Sep 2014

Delivery of Painkillers Now Becomes Faster and More Effective with Novel Microneedle Patch

Individuals who are squeamish about injections or are looking for a way to let collagen penetrate deeper into the skin may soon have a solution that is faster, more effective and painless. The key lies in a small adhesive patch topped with minuscule needles that is pioneered by researchers from the National University of Singapore (NUS).

8 Sep 2014

Nanomedicine News

Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Senesco Technologies Changes Name to Sevion Therapeutics

NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

Diagnostic Tool for Therapeutic Plasma Medicine

Novavax Presents Preclinical Data on RSV F-Protein Nanoparticle Vaccine Candidate at ICAAC 2014

Delivery of Painkillers Now Becomes Faster and More Effective with Novel Microneedle Patch

Cigarette Waste as a Source for Sustainable Supercapacitors

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Novel Technique Dramatically Increases Graphene's Elasticity

Laser-Induced Graphene for Printable and Biomedical Applications

Nanotubes Stabilize Carbyne, Paving Way for Advanced Electronics

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination